GlassScriptPhysician profile
Yassir Sonbol
NPI 1518039965
$4,733.56
in general payments reported to CMS, 2019-2025
38 companies · $895 in 2025
The $895 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $687 · 2021: $809 · 2022: $777 · 2023: $643 · 2024: $408 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.74 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,627.07 | 2020-2025 | Cardiomems, Esprit, Diamondback Coronary |
| Medtronic, INC. | $438.76 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Venaseal |
| Medtronic Vascular, INC. | $322.89 | 2019-2020 | |
| Amgen INC. | $251.57 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $167.35 | 2019-2025 | Watchman Flx, Resonate El Icd Vr |
| Novartis Pharmaceuticals Corporation | $135.61 | 2019-2022 | |
| Cardiovascular Systems INC. | $120.32 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $116.01 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $113.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $110.82 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $108.33 | 2020-2025 | Eliquis |
| Biosense Webster, INC. | $91.38 | 2025 | Carto 3 |
| Merck Sharp & Dohme LLC | $88.78 | 2022-2024 | Verquvo |
| Scpharmaceuticals INC. | $84.12 | 2023-2024 | |
| Amarin Pharma, INC. | $83.26 | 2020-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.42 | 2020-2023 | Lifevest |
| Pfizer INC. | $79.67 | 2019-2023 | |
| Artivion, INC. | $79.11 | 2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Shockwave Medical, INC | $64.91 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Antares Pharma, INC. | $55.77 | 2022 | |
| Ibsa Pharma INC. | $46.93 | 2021-2023 | Tirosint, Licart |
| Heartflow, INC. | $42.86 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $42.47 | 2019 | |
| Esperion Therapeutics, INC. | $41.12 | 2021-2023 | Nexletol |
| Cardiva Medical, INC. | $37.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.56 | 2024 | Jardiance |
| Cook Medical LLC | $33.79 | 2020-2023 | Zilver Ptx |
| Novo Nordisk INC | $30.18 | 2020 | |
| Astellas Pharma US INC | $24.96 | 2019 | |
| Eisai INC. | $23.66 | 2021 | |
| Edwards Lifesciences Corporation | $23.17 | 2022 | |
| Dexcom, INC. | $23.00 | 2024 | Dexcom G6 Transmitter |
| Kestra Medical Technology Services, INC. | $22.84 | 2025 | Assure Wcd |
| Preventice Services, LLC | $22.03 | 2021 | |
| Althera Pharmaceuticals LLC | $18.74 | 2022 | |
| Baxter Healthcare | $17.92 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Tactile Systems Technology INC | $15.96 | 2021 | |
| Angiodynamics, INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yassir Sonbol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.